Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Luce Boulanger"'
Autor:
Serge Nolet, Zaki El-Haffaf, Nelly Burnichon, Jessica Moramarco, André Lacroix, Pavel Hamet, Nadine Dumas, Luce Boulanger, Nada El Ghorayeb, Anne-Paule Gimenez Roqueplo, Isabelle Bourdeau
Publikováno v:
Clinical endocrinology. 86(3)
SummaryIntroduction Guidelines do not currently recommend routine systematic hormonal screening for pheochromocytoma (PHEO) in all/normotensive patients with neurofibromatosis type 1 (NF1), in contrast to other PHEO-predisposing genetic syndromes suc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::291d63b36971a6ddbaa04463d8c39d66
https://pubmed.ncbi.nlm.nih.gov/27787920
https://pubmed.ncbi.nlm.nih.gov/27787920
Publikováno v:
Endocrinology. 140:2836-2842
In aging, alterations of pituitary GH-releasing hormone (GHRH) receptor (GHRH-R)-binding sites have been proposed as one of the initiating factors contributing to the loss of somatotroph responsiveness to GHRH. Changes in the characteristics and/or c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5494b1f18fc9ec6e1c8d7ce58e45ff1c
https://doi.org/10.1210/endo.140.6.6760
https://doi.org/10.1210/endo.140.6.6760
Publikováno v:
Neuroendocrinology. 70:117-127
A site-directed polyclonal antipeptide antibody was generated in rabbits against segment 392–404 of the rat pituitary growth hormone-releasing hormone receptor (GHRH-R), using a multiple antigenic peptide system strategy of immunization. This C-ter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606152f3758eec7d5c559b46dcd7fbbd
https://doi.org/10.1159/000054466
https://doi.org/10.1159/000054466
Autor:
E Pintos, Luce Boulanger, Tomás García-Caballero, Rosalía Gallego, Gérard Morel, Pierrette Gaudreau
Publikováno v:
Neuroendocrinology. 70:128-136
Specific binding of growth hormone-releasing hormone (GHRH) to its plasma membrane receptor represents the first step of cellular signals leading to exocytotic GH secretion in the anterior pituitary. The GHRH receptor (GHRH-R) has been cloned and bel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9a7f9142339e423d89697ed76f97ff8
https://doi.org/10.1159/000054467
https://doi.org/10.1159/000054467
Publikováno v:
Brain Research. 673:39-46
We have investigated the effect of 5′-guanylylimidodiphosphate (Gpp(NH)p) and two disulfide bond reducing agents, reduced glutathione (GSH) and dithiothreitol (DTT), on the modulation of [ 125 I-Tyr 10 ]hGRF(1–44)NH 2 binding to GRF receptor bind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab4c06d62d9ac24a031eb510f5f6a940
https://doi.org/10.1016/0006-8993(94)01392-u
https://doi.org/10.1016/0006-8993(94)01392-u
Publikováno v:
Brain Research. 616:39-47
The identification of peptide bonds vulnerable to tissue peptidases is a valuable approach to design peptide agonists which exhibit a longer duration of action than the native molecules. Therefore, the kinetic of disappearance of rat growth hormone-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e23d0fa7cc4ef19802262eb31caf679a
https://doi.org/10.1016/0006-8993(93)90189-t
https://doi.org/10.1016/0006-8993(93)90189-t
Publikováno v:
Journal of Medicinal Chemistry. 35:1864-1869
Previous research on growth hormone-releasing factor analogues has used pituitary cell culture assay systems to evaluate in vitro their biological activity. However, binding assay systems in which receptor affinity and peptide stability can be assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a175f51b9bcc9abb1cfe9047aa293692
https://doi.org/10.1021/jm00088a023
https://doi.org/10.1021/jm00088a023
Publikováno v:
Peptides. 23(1)
Receptor binding analysis was performed in the renal medulla from 2-month-old rats, an extrapituitary tissue containing the highest level of GHRH receptor mRNA. At 4 °C, in the presence of a cocktail of protease inhibitors, binding of [ 125 I -Tyr 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec9f794e84156b33278723f53429be70
https://pubmed.ncbi.nlm.nih.gov/12126735
https://pubmed.ncbi.nlm.nih.gov/12126735
Publikováno v:
Clinical Biochemistry. 47:1154
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fb61781ed007a31c64bbb4dbc7422aa
https://doi.org/10.1016/j.clinbiochem.2014.06.062
https://doi.org/10.1016/j.clinbiochem.2014.06.062
Publikováno v:
Neuroendocrinology. 68(1)
In mammals, middle age and late adulthood is characterized by a decrease of growth hormone (GH) secretion and insulin-like growth factor 1 (IGF-1) serum levels, contributing to tissue and organ atrophy. This condition is related, at least in part, to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8190207c861d65025d9f0f3a594ac8af
https://pubmed.ncbi.nlm.nih.gov/9695935
https://pubmed.ncbi.nlm.nih.gov/9695935